Your browser doesn't support javascript.
loading
Alternative Complement Pathway Signature Determines Immunosuppression and Resistance to Immunotherapy Plus Tyrosine Kinase Inhibitor Combinations in Renal Cell Carcinoma.
Wang, Jiajun; Zhang, Sihong; Wang, Ying; Zhu, Yanjun; Xu, Xianglai; Guo, Jianming.
Afiliação
  • Wang J; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhang S; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wang Y; Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai,China.
  • Zhu Y; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: zhu.yanjun@zs-hospital.sh.cn.
  • Xu X; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: xl.xu@hotmail.com.
  • Guo J; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: guo.jianming@zs-hospital.sh.cn.
Urol Oncol ; 41(1): 51.e13-51.e23, 2023 01.
Article em En | MEDLINE | ID: mdl-36328922
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Limite: Humans Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Limite: Humans Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China